Member Info for Toukankahmoon

Tim

. . . but when?

I think that is the crucial point. There are answers to key questions that the BoD are holding off on. This has never been a good sign in the past.

Methinks she doth protest too much. Hit a nerve obviously 🙄

Whereas I’m not afraid to admit that it’s got to get above 140 to dig me out of the red.

Watching

In profit now

Implies a recent change. I cannot see how that is possible given current SP unless you’ve only recently started investing on a large scale?

Not as bad as one of my other penny shares Emmerson yesterday. It seems that the brown envelopes weren’t big enough and the planning for their only potash mine has been turned down again.

PoI

I sincerely doubt that. I am expecting that they will give more detail on the plans to push the two new drugs already identified through clinical trials.

And I doubt you have ever seen a twat other than in those grubby porn videos you watch.

What information that hasn’t already been released are you expecting to get?

My god I’ve awakened a monster!!!

More seriously I’m pleased someone else is finding use in ChatGPT. I find it very useful in all manner of things. Just one of which is say comparing two cars I’m interested in buying. Have fun.

. . that this is all happening a lot quicker than I thought.

If we can JV AVA6000 to bring in the necessary funds and offload development say halfway through P2 that is when this will 🚀

I know I’m sounding like a broken record, but AVA6000 will be JV with Novartis as soon as P2 data proves efficacy. We need money from this deal to fund gen 2 and 3.

WaG

Why do you have to goad people to start a fight on here ?

It’s posters with that sort of attitude that spoil this thread.

PS have me deleted again and I’ll just keep posting

Richphil

We all know this SP is sentiment driven but in the absence of news it performs like the majority of shares. A lot of folk bought at around 49p and up to around 57p. Those buyers will take profit it starts to slip much below 57p. You see it happen all the time. Personally in the absence of news I think we will bounce back up off current support level.

Yes we’re clinging on to the support level around 57p but as I posted already - I hoped we would bounce off it and start to rise again. If we drop through then it could turn ugly with 49p or thereabouts the next support level of significance 😬

Cindercone

I think they are just looking on the worst case scenario of the results from P1a and saying that in the unlikely event of us not being able to improve on that then there is still money to be made and patients lives to improve.

VR

I’m not falling for that🤣

Wyndrum, Thorn and others have explained it until we are blue in the face and all we get are potty mouthed character assassinations or our posts deleted.

PL75

You’re rabble rousing again. The sea of Green only appears on your BB when rampers start on the ludicrous posts. Such as last month it was fantastic News because we’d settled in cash and now this month it’s fantastic because we paid in shares.

Let’s face it for some posters on here any Avacta news is fantastically good.

I don’t think that this will impact the SP in my lifetime, but in the same way as we are getting resistance to antibiotics then in time it could be a concern.

Timster read about Darwin if you don’t understand evolution😄😄😄

Don’t think anyone is saying the platform doesn’t work.

What I am saying is that there is no T/O bidding war etc. a JV is a must in1H25.

And we aren’t gonna be millionaires any time soon if at all.

So stop misquoting me just so you can start an argument.

I said this in an earlier post. If you ask ChatGPT a leading question it will give you an answer that it thinks you want. In your case your question assumed there was a collaboration between Avacta and Novartis. If you ask “is there a collaboration then you get this”

There is no public evidence of a collaboration between Avacta and Novartis at this time. While Avacta has been involved in partnerships with companies like LG Chem and others in the biopharmaceutical space, a direct partnership with Novartis has not been announced.

Avacta has actively expanded its partnerships and research, notably in the area of its Affimer® and pre|CISION® platforms. For instance, the collaboration with LG Chem is focused on developing therapies across several disease areas and is significant for Avacta's drug development initiatives​

BUSINESS WIRE

​

BUSINESS WIRE

. However, there hasn't been any publicly disclosed collaboration specifically involving Novartis.

If you're seeking the latest updates, checking Avacta's press releases or industry news might provide any new developments on potential collaborations.

BTW

I first started working with AI systems in 1989 as part of a government funded initiative. I trained at Xerox who were world leaders at the time. Using frameworks on Sun Microsystems so I am not guessing.

There is no publicly confirmed strategic partnership between Avacta and AstraZeneca for developing immunotherapies. The information regarding a collaboration might have been confused with Avacta's partnerships with other pharmaceutical companies. Avacta is known for its collaborations to develop cancer treatments, particularly with its pre|CISION® platform, but AstraZeneca is not currently listed among its partners​